Phase II trial of S-1 plus leucovorin in patients with advanced gastric cancer and clinical prediction by S-1 pharmacogenetic pathway

被引：0
|
作者：
He, Ming-ming [1 ]
Xu, Rui-hua [1 ]
Zhang, Dong-sheng [1 ]
Wang, Feng [1 ]
机构：
[1] Sun Yat Sen Univ, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.e15028
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15028
引用
收藏
页数：1
相关论文
共 50 条
  • [31] S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial
    Koizumi, Wasaburo
    Narahara, Hiroyuki
    Hara, Takuo
    Takagane, Akinori
    Akiya, Toshikazu
    Takagi, Masakazu
    Miyashita, Kosei
    Nishizaki, Takashi
    Kobayashi, Osamu
    Takiyama, Wataru
    Toh, Yasushi
    Nagaie, Takashi
    Takagi, Seiichi
    Yamamura, Yoshitaka
    Yanaoka, Kimihiko
    Orita, Hiroyuki
    Takeuchi, Masahiro
    LANCET ONCOLOGY, 2008, 9 (03): : 215 - 221
  • [32] RANDOMIZED PHASE II TRIAL OF S-1 VERSUS S-1 PLUS OXALIPLATIN (SOX) IN PATIENTS WITH GEMCITABINE REFRACTORY PANCREATIC CANCER
    Okusaka, T.
    Ohkawa, S.
    Isayama, H.
    Fukutomi, A.
    Yamaguchi, K.
    Ikeda, M.
    Funakoshi, A.
    Nagase, M.
    Nakamori, S.
    Hamamoto, Y.
    ANNALS OF ONCOLOGY, 2012, 23 : 241 - 242
  • [33] RANDOMIZED PHASE II TRIAL OF S-1 PLUS IRINOTECAN VERSUS S-1 PLUS PACLITAXEL AS FIRST-LINE TREATMENT FOR ADVANCED GASTRIC CANCER (OGSG0402)
    Fujitani, K.
    Takiuchi, H.
    Sugimoto, N.
    Imamura, H.
    Iijima, S.
    Imano, M.
    Kimura, Y.
    Kurokawa, Y.
    Tsujinaka, T.
    Furukawa, H.
    ANNALS OF ONCOLOGY, 2010, 21 : 256 - 256
  • [34] Randomised phase II trial of S-1 plus oxaliplatin vs S-1 in patients with gemcitabine-refractory pancreatic cancer
    S Ohkawa
    T Okusaka
    H Isayama
    A Fukutomi
    K Yamaguchi
    M Ikeda
    A Funakoshi
    M Nagase
    Y Hamamoto
    S Nakamori
    Y Tsuchiya
    H Baba
    H Ishii
    Y Omuro
    M Sho
    S Matsumoto
    N Yamada
    H Yanagimoto
    M Unno
    Y Ichikawa
    S Takahashi
    G Watanabe
    G Wakabayashi
    N Egawa
    M Tsuda
    R Hosotani
    C Hamada
    I Hyodo
    British Journal of Cancer, 2015, 112 : 1428 - 1434
  • [35] Phase I/II study of docetaxel and S-1 in patients with advanced gastric cancer
    K Yamaguchi
    T Shimamura
    I Hyodo
    W Koizumi
    T Doi
    H Narahara
    Y Komatsu
    T Kato
    S Saitoh
    T Akiya
    M Munakata
    Y Miyata
    Y Maeda
    H Takiuchi
    S Nakano
    T Esaki
    F Kinjo
    Y Sakata
    British Journal of Cancer, 2006, 94 : 1803 - 1808
  • [36] A phase Ⅱ trial of oxaliplatin plus S-1 as a first-line chemotherapy for patients with advanced gastric cancer
    YANG Lin
    SONG Yan
    ZHOU Ai-ping
    QIN Qiong
    CHI Yihebali
    HUANG Jing
    WANG Jin-wan
    中华医学杂志（英文版）, 2013, 126 (18) : 3470 - 3474
  • [37] Phase II study of cetuximab plus S-1/cisplatin therapy in Japanese patients with advanced gastric cancer
    Yamaguchi, Kensei
    Fuse, Nozomu
    Komatsu, Yoshito
    Fujii, Hirofumi
    Hironaka, Shuichi
    Omuro, Yasushi
    Muro, Kei
    Yasui, Hirofumi
    Ueda, Shinya
    Nishina, Tomohiro
    Watanabe, Morihiro
    Ohtsu, Atsushi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2021, 51 (06) : 879 - 885
  • [38] A randomized phase II study comparing S-1 plus oxaliplatin with S-1 monotherapy for elderly patients with advanced gastric cancer: WJOG8315G
    Makiyama, Akitaka
    Shoji, Hirokazu
    Kawakami, Hisato
    Tamura, Takao
    Sugiyama, Keiji
    Hara, Hiroki
    Nagase, Michitaka
    Nishikawa, Kazuo
    Esaki, Taito
    Izawa, Naoki
    Nakamura, Masato
    Ando, Takayuki
    Miura, Yuji
    Narita, Yukiya
    Shimokawa, Mototsugu
    Yamazaki, Kentaro
    Hironaka, Shuichi
    Hyodo, Ichinosuke
    Muro, Kei
    ANNALS OF ONCOLOGY, 2023, 34 : S1390 - S1390
  • [39] Clinical Study of S-1 Plus Oxaliplatin Versus S-1 Plus Cisplatin as First-Line Treatment for Elderly Patients with Advanced Gastric Cancer
    Bo Deng-feng
    Hu Xiu-fu
    JOURNAL OF INTERNATIONAL TRANSLATIONAL MEDICINE, 2015, 3 (04): : 238 - 242
  • [40] A phase II multicentric trial of combined chemotherapy with gemcitabine plus S-1 in patients with advanced pancreatic cancer
    Ohkawa, S.
    Amano, A.
    Ueno, M.
    Miyakawa, K.
    Sugimori, K.
    Tanaka, K.
    Kida, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345